SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Wipro shines on securing multi-million dollar deal from AstraZeneca

21 Dec 2011 Evaluate

Wipro is currently trading at Rs. 400.00, up by 4.30 points or 1.09% from its previous closing of Rs. 395.70 on the BSE.

The scrip opened at Rs. 401.30 and has touched a high and low of Rs. 401.90 and Rs. 396.65 respectively. So far 18,000 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 496.30 on 28-Dec-2010 and a 52 week low of Rs. 310.20 on 19-Aug-2011.

Last one week high and low of the scrip stood at Rs. 417.50 and Rs. 392.05 respectively. The current market cap of the company is Rs. 98,312.00 crore.

The promoters holding in the company stood at 79.17% while Institutions and Non-Institutions held 9.23% and 9.90% respectively.

Wipro, India’s third largest IT bellwether has been selected as an IT partner for a multi-million dollar engagement with AstraZeneca, a leading global biopharmaceutical company. However, the deal size was not disclosed.

The company has been selected as one of four IT partners, after a six-month evaluation period, to enhance AstraZeneca’s end user computing infrastructure.

Wipro’s net profit for the second quarter of the current fiscal declined by 10.37% at Rs 1050.6 crore as compared to Rs 1172.1 crore for the corresponding quarter  of the previous fiscal. The company’s total income increased by 19.69% at Rs 8011.5 crore for the quarter under review as compared to Rs 6693.7 crore for the second quarter of the previous year.

Wipro Share Price

204.85 1.95 (0.96%)
10-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
TCS 2524.35
Infosys 1292.35
HCL Tech. 1450.90
Wipro 204.85
Tech Mahindra 1440.40
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×